| Entry |
|
|---|
| Name |
Nemvaleukin alfa (USAN/INN) |
|---|
| Formula |
C1501H2378N420O461S23
|
|---|
| Exact mass |
34398.9123
|
|---|
| Mol weight |
34421.03
|
|---|
| Sequence |
SKNFHLRPRD LISNINVIVL ELKGSETTFM CEYADETATI VEFLNRWITF SQSIISTLTG
GSSSTKKTQL QLEHLLLDLQ MILNGINNYK NPKLTRMLTF KFYMPKKATE LKHLQCLEEE
LKPLEEVLNL AQGSGGGSEL CDDDPPEIPH ATFKAMAYKE GTMLNCECKR GFRRIKSGSL
YMLCTGNSSH SSWDNQCQCT SSATRNTTKQ VTPQPEEQKE RKTTEMQSPM QPVDQASLPG
HCREPPPWEN EATERIYHFV VGQMVYYQCV QGYRALHRGP AESVCKMTHG KTRWTQPQLI
CTG
(Disulfide bridge: 31-116, 141-285, 184-242, 269-301) |
|---|
| Type |
Peptide |
|---|
| Efficacy |
Antineoplastic, Immunostimulant, Biological response modifier |
|---|
| Comment |
Treatment of metastatic solid malignancies
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Interleukin receptors
IL2RA (CD25)
D12371 Nemvaleukin alfa (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
